Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.
Cabral de Menezes Filho
H
H
Pediatric Endocrinology Unit, Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Rodrigues
J M
JM
Radonsky
V
V
Della Manna
T
T
Kuperman
H
H
Steinmetz
L
L
Dichtchekenian
V
V
Damiani
D
D
Setian
N
N
D000469:Alkaline Phosphatase / Q000097:blood*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D016723:Bone Remodeling / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004164:Diphosphonates / Q000008:administration & dosage* / Q000627:therapeutic use; D015536:Down-Regulation; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male; D010013:Osteogenesis Imperfecta / Q000097:blood* / Q000188:drug therapy* / Q000503:physiopathology; D000077268:Pamidronate; D012720:Severity of Illness Index
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000469:Alkaline Phosphatase; D000077268:Pamidronate